Skip to main content

Z08 vs Z40-Z53

Z08 (Encounter for follow-up examination after completed treatment for malignant neoplasm) compared with Z40-Z53 (Encounters for other specific health care (Z40-Z53)), from the official CMS tabular data.

Summary

These codes can be reported together when both conditions are documented, because Z40-Z53 lists Z08 under Excludes2, which marks them as distinct conditions.

Official rule
What is different?

The conditions named and billing status.Z08 is “Encounter for follow-up examination after completed treatment for malignant neoplasm”; Z40-Z53 is “Encounters for other specific health care (Z40-Z53)”. Z40-Z53 is a non-billable header; Z08 is billable.

Registry fact

Can these codes be reported together?

Yes, when both are documented.Z40-Z53 lists Z08 under Excludes2: “follow-up examination for medical surveillance after treatment (Z08-Z09)”. Excludes2 marks distinct conditions that may both be reported when both are documented.

Official ruleGuide: Excludes1 vs Excludes2

Is there an Excludes1 relationship?

None.Neither entry carries an Excludes1 note that names the other code. Z08 carries 1 Excludes1 note covering other codes; the side-by-side table quotes them.

Official rule

Is there an Excludes2 relationship?

Yes.Z40-Z53’s tabular entry: “follow-up examination for medical surveillance after treatment (Z08-Z09)”. The note covers Z08.

Official ruleGuide: Excludes1 vs Excludes2

Is one more specific?

Not comparable.The codes sit in different categories; specificity is only comparable within one category.

Is one a parent or header code?

One is a header.Z40-Z53 is a non-billable header, but Z08 is not one of its subdivisions.

Registry fact

Are there sequencing instructions?

None.Neither entry carries a Code First or Use Additional Code note that names the other.

Official rule

Are there other coding relationships?

None found.No laterality, encounter-phase, Table of Neoplasms, Table of Drugs and Chemicals, or history-versus-active-disease relationship links these codes.

MedCoder-derived

Official rule: a tabular instructional note or a section of the ICD-10-CM Official Guidelines, quoted as published. Registry fact: the codes’ own published attributes (titles, billable status, position in the hierarchy, code set). MedCoder-derived: a reading MedCoder computes from those facts; it is not itself a rule. How to read the labels

Can these codes be reported together?

Informational

Excludes2 relationship

Z40-Z53
Encounters for other specific health care (Z40-Z53)
Z08
Encounter for follow-up examination after completed treatment for malignant neoplasm

What we found

Yes, when both are documented.Z40-Z53 carries an Excludes2 note covering Z08: “follow-up examination for medical surveillance after treatment (Z08-Z09)”

Excludes2 marks distinct conditions — both may be reported when both are documented.

What to review

Report both only when the documentation supports both conditions; otherwise report the one documented.

Guide: Excludes1 vs Excludes2Check these on a claim

Why it matters

An Excludes2 note means the excluded condition is not part of the code above it, but a patient can have both. Report both when both are documented.

Source / rule

CMS ICD-10-CM tabular instructional notes

Official guidance behind these answers

  • Section I.A.12.b — Excludes2 · applies to: Excludes2

    A type 2 Excludes note represents “Not included here.” An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

    ICD-10-CM Official Guidelines FY2026

Quoted from the ICD-10-CM Official Guidelines for Coding and Reporting in effect for the release shown. The tabular notes above are the code-level instruction; these sections are the convention that says how such a note is applied. Source document (CMS PDF) · Release and checksum

Side by side

Z08Encounter for follow-up examination after completed treatment for malignant neoplasmZ40-Z53Encounters for other specific health care (Z40-Z53)
Billing statusBillableNon-billable header
ClassificationZ00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99)Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99)
DefinitionEncounter for follow-up examination after completed treatment for malignant neoplasm is a billable ICD-10-CM diagnosis code (Z08).Encounters for other specific health care (Z40-Z53) is a non-billable ICD-10-CM category code (Z40-Z53).
Includes
Medical surveillance following completed treatment
Categories Z40-Z53 are intended for use to indicate a reason for care. They may be used for patients who have already been treated for a disease or injury, but who are receiving aftercare or prophylactic care, or care to consolidate the treatment, or to deal with a residual state
Excludes1
aftercare following medical care (Z43-Z49, Z51)
Excludes2
examinations related to pregnancy and reproduction (Z30-Z36, Z39.-)
follow-up examination for medical surveillance after treatment (Z08-Z09)
Use additional code
code to identify any acquired absence of organs (Z90.-)
code to identify the personal history of malignant neoplasm (Z85.-)

Notes are the code’s own tabular entry, quoted as published. A note that names the other code is the one the verdict above rests on.

Derived from the official CMS ICD-10-CM tabular data (FY2027). A coding-rule comparison, not billing advice: payer-specific edits and medical-necessity policy are outside its scope. All data sources